Publication | Closed Access

Preparation and characterization of PEGylated liposomal Doxorubicin targeted with leptin-derived peptide and evaluation of their anti-tumor effects, in vitro and in vivo in mice bearing C26 colon carcinoma

Leptin-derived PeptidePegylated Liposomal DoxorubicinDrug TargetingMedicinePeptide TherapeuticTumor TargetingAnti-cancer AgentPharmacologyRadiation OncologyCancer ResearchTumor BiologyDrug DiscoveryAnti-tumor Effects